Skip to content

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01322685
Enrollment
40
Registered
2011-03-24
Start date
2010-07-31
Completion date
2011-06-30
Last updated
2011-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Tuberculosis

Keywords

Tuberculosis, Lung cancer

Brief summary

The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

Interventions

None listed

Sponsors

Taipei Medical University WanFang Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
17 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Health group: between 17 to 90 years old * Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old

Exclusion criteria

* Women subjects are before or after the period within two days

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026